Skip to main content

Advertisement

SpringerLink
Log in

Triptan safety during pregnancy: a Norwegian population registry study

  • PHARMACO-EPIDEMIOLOGY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Knowledge on triptan safety during pregnancy remains limited to their class effect or studies on sumatriptan. Our aim was to evaluate the individual effect of four most frequently used triptans on several pregnancy outcomes. We used the Norwegian prescription database to access information on triptans redeemed by pregnant women living in Norway between 2004 and 2007. This database was linked to the Medical Birth Registry of Norway covering every institutional delivery in Norway and providing information on pregnancy, delivery, maternal and neonatal health. Estimates of associations with pregnancy outcomes were obtained by Generalised Estimation Equations analysis. Of the 181,125 women in our study, 1,465 (0.8 %) redeemed triptans during pregnancy, and 1,095 (0.6 %) redeemed triptans before pregnancy only (disease comparison group). The population comparison group comprised the remaining 178,565 women. Using this group as reference, we found no associations between triptan redemption during pregnancy and congenital malformations. Second trimester redemption was associated with postpartum haemorrhage (adjusted OR 1.57; 95 % CI 1.19–2.07). The disease comparison group had an increased risk of major congenital malformations (adjusted OR 1.48; 95 % CI 1.11–1.97), low birth weight (adjusted OR 1.39; 95 % CI 1.08–1.81), and preterm birth (adjusted OR 1.30; 95 % CI 1.06–1.60). The association of triptans with postpartum hemorrhage could be attributable to decreased platelet agreeability occurring in severe migraine. Likewise, the increased risk of major congenital malformations and other adverse pregnancy outcomes in the disease comparison group might be attributable to migraine severity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ertresvåg J, Zwart J-A, Helde G, Johnsen H-J, Bovim G. Headache and transient focal neurological symptoms during pregnancy, a prospective cohort. Acta Neurol Scand. 2005;111:233–7.

    Article  PubMed  Google Scholar 

  2. Sances G, Granella F, Nappi RE, Fignon A, Ghiotto N, Polatti F, et al. Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia. 2003;23(3):197–205.

    Article  PubMed  CAS  Google Scholar 

  3. Melhado E, Maciel JA Jr, Guerreiro CA. Headaches during pregnancy in women with a prior history of menstrual headaches. Arq Neuropsiquiatr. 2005;63(4):934–40. doi:/S0004-282x2005000600006.

    Article  PubMed  Google Scholar 

  4. Marcus D, Scharff L, Turk D. Longitudinal prospective study of headache during pregnancy and postpartum. Headache. 1999;39(9):625–32.

    Article  PubMed  CAS  Google Scholar 

  5. Scharff L, Marcus DA, Turk DC. Headache during pregnancy and in the postpartum: a prospective study. Headache. 1997;37(4):203–10.

    Article  PubMed  CAS  Google Scholar 

  6. Mattsson P, Svardsudd K, Lundberg PO, Westerberg CE. The prevalence of migraine in women aged 40–74 years: a population-based study. Cephalalgia. 2000;20(10):893–9.

    Article  PubMed  CAS  Google Scholar 

  7. Granella F, Sances G, Pucci E, Nappi R, Chiotto N, Nappi G. Migraine with aura and reproductive life events: a case control study. Cephalalgia. 2000;20(8):701–7.

    PubMed  CAS  Google Scholar 

  8. Maggioni F, Alessi C, Maggino T, Zanchin G. Headache during pregnancy. Cephalalgia. 1997;17(7):765–9.

    Article  PubMed  CAS  Google Scholar 

  9. Facchinetti F, Allais G, Nappi RE, D’Amico R, Marozio L, Bertozzi L, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009;29(3):286–92. doi:10.1111/j.1468-2982.2008.01704.x.

    Article  PubMed  CAS  Google Scholar 

  10. Cripe SM, Frederick IO, Qiu C, Williams MA. Risk of preterm delivery and hypertensive disorders of pregnancy in relation to maternal co-morbid mood and migraine disorders during pregnancy. Paediatr Perinat Epidemiol. 2011;25(2):116–23. doi:10.1111/j.1365-3016.2010.01182.x.

    Article  PubMed  Google Scholar 

  11. Bushnell CD, Jamison M, James AH. Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ. 2009;338:1–8. doi:10.1136/bmj.b664.

    Article  Google Scholar 

  12. Chen HM, Chen SF, Chen YH, Lin HC. Increased risk of adverse pregnancy outcomes for women with migraines: a nationwide population-based study. Cephalalgia. 2010;30(4):433–8. doi:10.1111/j.1468-2982.2009.01935.x.

    PubMed  Google Scholar 

  13. Facchinetti F, Allais G, D’Amico R, Benedetto C, Volpe A. The relationship between headache and preeclampsia: a case-control study. Eur J Obstet Gynecol Reprod Biol. 2005;121(2):143–8. doi:10.1016/j.ejogrb.2004.12.020.

    Article  PubMed  CAS  Google Scholar 

  14. Adeney KL, Williams MA, Miller RS, Frederick IO, Sorensen TK, Luthy DA. Risk of preeclampsia in relation to maternal history of migraine headaches. J Matern Fetal Neonatal Med. 2005;18(3):167–72. doi:10.1080/14767050500260566.

    Article  PubMed  Google Scholar 

  15. Leveno KJ, Cunningham FG, Alexander JM, Bloom SL, Casey BM, Dashe JS, et al. Williams manual of obstetrics pregnancy complications. 22nd ed. New York: McGraw-Hill; 2007.

    Google Scholar 

  16. Nezvalová-Henriksen K, Spigset O, Nordeng H. Maternal characteristics and migraine pharmacotherapy during pregnancy: cross sectional analysis of data from a large cohort study. Cephalalgia. 2009;29:1267–76.

    Article  PubMed  Google Scholar 

  17. Nezvalová-Henriksen K, Spigset O, Nordeng H. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian mother and child cohort study. Headache. 2010;50:563–75.

    Article  PubMed  Google Scholar 

  18. Nezvalova-Henriksen K, Spigset O, Nordeng HM. Errata in “Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the norwegian mother and child cohort study”. Headache. 2012;52(8):1319–20. doi:10.1111/j.1526-4610.2012.02207.x.

    Article  PubMed  Google Scholar 

  19. Chu MK, Buse DC, Bigal ME, Serrano D, Lipton RB. Factors associated with triptan use in episodic migraine: results from the American migraine prevalence and prevention study. Headache. 2012;52(2):213–23.

    Article  PubMed  Google Scholar 

  20. Kαllen B, Nilsson E, Otterblad Olausson P. Delivery outcome after maternal use of drugs for migraine: a register study in Sweden. Drug Saf. 2011;34(8):691–703. doi:10.2165/11590370-000000000-00000.

    Article  Google Scholar 

  21. Kallen B, Lygner PE. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan. Headache. 2001;41(4):351–6.

    Article  PubMed  CAS  Google Scholar 

  22. Olesen C, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. Pregnancy outcome following prescription for sumatriptan. Headache. 2000;40(1):20–4.

    Article  PubMed  CAS  Google Scholar 

  23. GlaxoSmithKline. The Sumatriptan/Naratriptan/Treximet Pregnancy. 2012.

  24. Norwegian Institute of Public Health. The Medical Birth Registry of Norway. Oslo, Norway. http://www.fhi.no/helseregistre/medisinsk-fodselsregister (2013).

  25. Norwegian Institute of Public Health. The Norwegian Prescription Database. Oslo, Norway. http://www.fhi.no/helseregistre/reseptregisteret (2013).

  26. Al-Zirqi I, Stray-Pedersen B, Forsen L, Daltveit AK, Vangen S. Validation study of uterine rupture registration in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand. 2013;. doi:10.1111/aogs.12148.

    PubMed  Google Scholar 

  27. Vikanes A, Magnus P, Vangen S, Lomsdal S, Grjibovski AM. Hyperemesis gravidarum in the Medical Birth Registry of Norway—a validity study. BMC Pregnancy Childbirth. 2012;12:115. doi:10.1186/1471-2393-12-115.

    Article  PubMed  Google Scholar 

  28. Engeland A, Bjorge T, Daltveit AK, Vollset SE, Furu K. Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand. 2009;88(10):1083–9. doi:10.1080/00016340903128454.

    Article  PubMed  Google Scholar 

  29. Melve KK, Lie RT, Skjaerven R, Van Der Hagen CB, Gradek GA, Jonsrud C, et al. Registration of down syndrome in the Medical Birth Registry of Norway: validity and time trends. Acta Obstet Gynecol Scand. 2008;87(8):824–30. doi:10.1080/00016340802217184.

    Article  PubMed  Google Scholar 

  30. Baghestan E, Bordahl PE, Rasmussen SA, Sande AK, Lyslo I, Solvang I. A validation of the diagnosis of obstetric sphincter tears in two Norwegian databases, the Medical Birth Registry and the Patient Administration System. Acta Obstet Gynecol Scand. 2007;86(2):205–9. doi:10.1080/00016340601111364.

    Article  PubMed  Google Scholar 

  31. Irgens LM. The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand. 2000;79(6):435–9.

    Article  PubMed  CAS  Google Scholar 

  32. ATC/DDD Index 2008 [database on the Internet]. Available from: < http://www.whocc.no/atcddd/> (2009). Accessed 3 June 2009.

  33. World Health Organization. International Classification of Diseases. 2013. http://www.who.int/classifications/icd/en/.

  34. Fiore M, Shields KE, Santanello N, Goldberg MR. Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004. Cephalalgia. 2005;25(9):685–8. doi:10.1111/j.1468-2982.2004.00929.x.

    Article  PubMed  CAS  Google Scholar 

  35. Banhidy F, Acs N, Horvath-Puho E, Czeizel AE. Maternal severe migraine and risk of congenital limb deficiencies. Birth Defects Res A. 2006;76(8):592–601. doi:10.1002/bdra.20288.

    Article  CAS  Google Scholar 

  36. Williams MA, Peterlin BL, Gelaye B, Enquobahrie DA, Miller RS, Aurora SK. Trimester-specific blood pressure levels and hypertensive disorders among pregnant migraineurs. Headache. 2011;51(10):1468–82. doi:10.1111/j.1526-4610.2011.01961.x.

    Article  PubMed  Google Scholar 

  37. Nappi G, Sandrini G, Sances G. Tolerability of the triptans: clinical implications. Drug Saf. 2003;26(2):93–107.

    Article  PubMed  CAS  Google Scholar 

  38. Gupta S, Hanff LM, Visser W, Steegers EA, Saxena PR, Vulto AG, et al. Functional reactivity of 5-HT receptors in human umbilical cord and maternal subcutaneous fat arteries after normotensive or pre-eclamptic pregnancy. J Hypertens. 2006;24(7):1345–53. doi:10.1097/01.hjh.0000234115.40648.88.

    Article  PubMed  CAS  Google Scholar 

  39. Blair EM, Nelson KB. Migraine and preterm birth. J perinatol. 2011;31(6):434–9. doi:10.1038/jp.2010.148.

    Article  PubMed  CAS  Google Scholar 

  40. Marozio L, Facchinetti F, Allais G, Nappi RE, Enrietti M, Neri I, et al. Headache and adverse pregnancy outcomes: a prospective study. Eur J Obstet Gynecol Reprod Biol. 2012;161(2):140–3. doi:10.1016/j.ejogrb.2011.12.030.

    Article  PubMed  Google Scholar 

  41. Cripe SM, Sanchez S, Lam N, Sanchez E, Ojeda N, Tacuri S, et al. Depressive symptoms and migraine comorbidity among pregnant Peruvian women. J Affect Disord. 2010;122(1–2):149–53. doi:10.1016/j.jad.2009.07.014.

    Article  PubMed  Google Scholar 

  42. Rossi C, Pini LA, Cupini ML, Calabresi P, Sarchielli P. Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur J Clin Pharmacol. 2008;64(1):1–8. doi:10.1007/s00228-007-0391-4.

    Article  PubMed  CAS  Google Scholar 

  43. Melve K, Lie R, Skjærven R, Van Der Hagen C, Gradek G, Jonsrud C, et al. Registration of down syndrome in the Medical Birth Registry of Norway: validity and time trends. Acta Obstet Gynecol Scand. 2008;87:824–30.

    Article  PubMed  Google Scholar 

  44. Kubon C, Sivertsen A, Vindenes HA, Abyholm F, Wilcox A, Lie RT. Completeness of registration of oral clefts in a medical birth registry: a population-based study. Acta Obstet Gynecol Scand. 2007;86(12):1453–7. doi:10.1080/08037050701645090.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, P.O. Box 1065, Blindern, 0316, Oslo, Norway

    Kateřina Nezvalová-Henriksen & Hedvig Nordeng

  2. Department of Clinical Pharmacology, St Olav’s University Hospital, Trondheim, Norway

    Olav Spigset

  3. Department of Laboratory Medicine, Children’s and Women’s Health, Norwegian University of Science and Technology, Trondheim, Norway

    Olav Spigset

  4. Division of Mental Health, The Norwegian Institute of Public Health, Oslo, Norway

    Hedvig Nordeng

Authors
  1. Kateřina Nezvalová-Henriksen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olav Spigset
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hedvig Nordeng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kateřina Nezvalová-Henriksen.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 98 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nezvalová-Henriksen, K., Spigset, O. & Nordeng, H. Triptan safety during pregnancy: a Norwegian population registry study. Eur J Epidemiol 28, 759–769 (2013). https://doi.org/10.1007/s10654-013-9831-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-013-9831-x

Keywords

Search

Navigation